Drugs / Cultured ASCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05610878 | Nov 2020 → Dec 2025 overdue | craniofacial microsomia, neurodevelopmental disorder with progressive movement abnormalities | University of the Punjab | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cultured ASCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05610878 ↗ |
| Route | Other | “1,00,000 cells per ml of fat will be mixed, transferred to 10 cc syringes and injected at deformity site.” NCT05610878 ↗ |